share_log

賽生藥業:交易所通告 - 復牌

SCICLONE PHARMA: EXCHANGE NOTICE - RESUMPTION OF TRADING

香港交易所 ·  Apr 1 20:32
Summary by Moomoo AI
賽生藥業控股有限公司(證券代號:06600)宣布,公司股份將於2024年4月2日上午九時正恢復在香港交易所的買賣。此次復牌意味著賽生藥業的股票交易將重新開放,投資者可再次進行交易。
賽生藥業控股有限公司(證券代號:06600)宣布,公司股份將於2024年4月2日上午九時正恢復在香港交易所的買賣。此次復牌意味著賽生藥業的股票交易將重新開放,投資者可再次進行交易。
SESONG PHARMACEUTICAL HOLDINGS LIMITED (STOCK CODE: 06600) ANNOUNCED THAT THE COMPANY'S SHARES WILL RESUME TRADING ON THE HONG KONG EXCHANGE AT 9:00 A.M. ON APRIL 2, 2024. This reissue means that stock trading in Sai Son Pharmaceuticals will be reopened, allowing investors to trade again.
SESONG PHARMACEUTICAL HOLDINGS LIMITED (STOCK CODE: 06600) ANNOUNCED THAT THE COMPANY'S SHARES WILL RESUME TRADING ON THE HONG KONG EXCHANGE AT 9:00 A.M. ON APRIL 2, 2024. This reissue means that stock trading in Sai Son Pharmaceuticals will be reopened, allowing investors to trade again.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more